Thurella AG, headquartered in Switzerland (CH), is a prominent player in the biotechnology industry, specialising in innovative solutions for the pharmaceutical and healthcare sectors. Founded in 2015, the company has rapidly established itself as a leader in the development of advanced biopharmaceutical products, focusing on therapeutic proteins and monoclonal antibodies. With a commitment to quality and sustainability, Thurella AG offers unique services that streamline the drug development process, ensuring efficiency and efficacy. The company’s state-of-the-art facilities and expert team have enabled it to achieve significant milestones, including successful collaborations with major pharmaceutical firms. Recognised for its cutting-edge research and development, Thurella AG continues to enhance its market position, contributing to the advancement of biotechnological applications that improve patient outcomes globally.
We don't have data for Thurella AG, but we can show you information about their parent organization instead.
View parent company